Viral Immunology

Papers
(The TQCC of Viral Immunology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Sec37
Investigating the Immunogenic Properties of a Mutagenized NS3/4A-Based HCV Genotype 3a DNA Vaccine32
Interleukin-4 Promotes Human Metapneumovirus Replication Through the JAK/STAT6 Pathway20
Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review19
Evaluation of an Immunoglobulin E Capture Enzyme-Linked Immunosorbent Assay for the Early Diagnosis of Dengue15
Epidemiologic Characteristics of SARS-CoV-2 Omicron BA.5.1.3 Variant and the Protection Provided By Inactivated Vaccination13
Plasma Levels of Secreted Cytokines in Virologically Controlled HIV-Infected Aging Adult Individuals on Long-Term Antiretroviral Therapy12
Epstein-Barr Virus Antibodies and Autoimmune Diseases: A Bidirectional Mendelian Randomization Analysis12
Peripheral Circulating Exosomal-miRNAs Potentially Mediate the Sensitivity to Interferon Treatment in Chronic Hepatitis B Virus Patients12
The Impact of Vaccination on the Likelihood of COVID-19 Infection12
Hybrid Immunity Against Severe Acute Respiratory Syndrome Coronavirus 212
Anatomical Distribution of Myeloid-Derived Suppressor Cells During HIV Infection11
Human Endogenous Retroviruses and Toll-Like Receptors10
Memory T Cells Subpopulations in a Cohort of COVID-19 Vaccinated or Recovered Subjects10
Letter to the Editor: Should Viruses Exist? A Brief Reflection on the (Re)evolution of the Virus–Life Relationship10
Scavenger Receptors in the Pathogenesis of Viral Infections9
Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome9
Interleukin-36gamma Mediates the In Vitro Activation of CD8+ T Cells from Patients Living with Chronic Human Immunodeficiency Virus-1 Infection9
Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study9
A New Year, and a New Variant to Deal With8
Virus-Induced Programmed Cell Death: To Die, or Not to Die?8
Measles and Rubella Seroprevalence Among Children and Adolescents of Córdoba, Argentina: A Cross-Section Study in the Context of the Elimination Program8
Clinical Significance of BTLA and HVEM Expression on Circulating CD4+ T and CD8+ T Cells in Chronic Hepatitis B Virus Infection8
Acknowledgment of Reviewers 20248
Correlation of COVID-19 Severity and Immunoglobulin Presence Against Spike and Nucleocapsid Proteins in SARS-CoV-28
Interleukin-33 Reinvigorates Antiviral Function of Viral-Specific CD8+ T Cells in Chronic Hepatitis B Virus Infection8
Immunoinformatics-Based Identification of the Conserved Immunogenic Peptides Targeting of Zika Virus Precursor Membrane Protein8
Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports7
Correction to: The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses by Ramírez Hernández et al. Viral Immunol. 2021;34(3):165–1737
Clinical Characteristics and Immune Status of Patients with Severe Fever with Thrombocytopenia Syndrome7
Evaluation of an F Protein-Based Recombinant Protein for Immunization Against Respiratory Syncytial Virus7
Dengue Virus Increases the Expression of TREM-1 and CD10 on Human Neutrophils7
Persistence of RNA Viruses in the Respiratory Tract: An Overview7
Human Cytomegalovirus Infection and Cardiovascular Disease: Current Perspectives7
Acknowledgment of Reviewers 20237
No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April–July 2024)7
Cross-Neutralization of Vanguard C4 Vaccine Against Australian Isolates of Canine Parvovirus Variants CPV-2a, CPV-2b, and CPV-2c7
Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider?6
Knowledge on Human Papillomavirus Infections, Cancer Biology, Immune Interactions, Vaccination Coverage and Common Treatments: A Comprehensive Review6
Differential Expression Patterns of Indoleamine 2,3-Dioxygenase 1 and Other Tryptophan and Arginine Catabolic Pathway Genes in Dengue Correlate with Clinical Severity-Pilot Study Results6
Call for Papers: Viral Immunology6
The Potential of mRNA Vaccines to Fight Against Viruses6
A Series of Articles About T Cells and Vaccines6
Comparison of Immunogenicity Between a Candidate Live Attenuated Vaccine and an Inactivated Vaccine for Cache Valley Virus6
Hepatitis B Virus Envelope Antigen and Hepatitis B Virus Surface Antigen Both Contribute to the Innate Immune Response During Persistent Hepatitis B Virus Infection5
Cytokine Profile in Patients with Postacute Sequelae of COVID-195
Characterization of Pre-Existing Neutralizing Antibody to Human Adenovirus Types 5 and 49 and Simian Type 23 in Chinese Population5
A Stable mRNA-Based Novel Multi-Epitope Vaccine Designs Against Infectious Heartland Virus by Integrated Immunoinformatics and Reverse Vaccinology Approaches5
Differential Reactivation of Cytomegalovirus and Epstein–Barr Virus in Patients with B Cell Lymphoma5
Letter to the Editor: Can Viral RNAs Become Attached to the Cell Surface? Potential Consequences of a Hypothetical and Novel Way5
Investigation of Fas (APO-1)-Related Apoptosis in Piglets Intradermally or Intramuscularly Vaccinated with a Commercial PRRSV MLV5
Poly(Lactide-co-Glycolide) Nanoparticle-Mediated Vaccine Delivery of Encapsulated Surface Antigen Protein of Hepatitis B Virus Elicits Effective Immune Response5
Altered TLR7 Expression-Mediated Immune Modulation Is Supportive of Persistent Replication and Intrauterine Transmission of HBV5
Enhanced Programmed Cell Death Protein 1/Programmed Cell Death Ligand 1 Expression Induced by Severe Influenza A Virus Infection Impairs Host's Antiviral Response5
Intracellular Toll-Like Receptors Modulate Adaptive Immune Responses in Head and Neck Cancer5
Correlation Between TWEAK Serum Level and HTLV-1 Proviral Load in HAM/TSP4
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma4
Let Us Not Forget the Cells4
Hepatitis C Virus Alters Macrophage Cholesterol Metabolism Through Interaction with Scavenger Receptors4
Elevation of Myeloperoxidase Correlates with Disease Severity in Patients with Hantaan Virus Infection4
Asymptomatic COVID-19 Reinfection in a Pediatric Patient with Heterotaxy Syndrome4
Advances in the Epidemiology, Pathogenesis, Diagnostic Methods, and Vaccine Development of Dengue Fever: A Comprehensive Review4
Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Di4
The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients4
Response to Daungsupawong/Wiwanitkit LTE4
The Nuclear Pore Complex 62 Suppression Inhibits Coxsackievirus B Replication and Inflammatory Response4
The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis4
Humoral and Cellular Immune Response to SARS-CoV-2 in Children Undergoing Cardiac Surgery4
Interleukin-18 Plays a Positive Feedback Activity to Natural Killer-Like B Cells in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure4
Immunogenic Response Assessment of Hepatitis Delta Virus Antigen from Pakistani Isolate in Rabbits Using a Prokaryotic Expression System4
Correction to: A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection, by Kim, et al. Viral Immunology 2023;36(3):203–208; doi: 10.1089/vi4
Cross-Reactive Profile Against Two Conserved Coronavirus Antigens in Sera from SARS-CoV-2 Hybrid and Vaccinated Immune Donors4
TLR3\TLR7 as Differentially Expressed Markers Among Viral, Nonviral, and Autoimmune Diseases in Egyptian Patients4
0.67285299301147